Evolent Health Inc. (evh 3.5 12/01/29)
13F holders, Q4 2025 (December 31)1holders −2
0new positions
2sold out
$0.69avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Evolent Health Inc. (evh 3.5 12/01/29) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holder was Ewing Morris & Co. Investment Partners Ltd. ($7.2M).
- Company
- Evolent Health Inc. (evh 3.5 12/01/29)
- CUSIP
- 30050BAH4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $9.7M |
All 13F filers, Q3 2025 → Q4 2025: 500,000 shares bought and 11,904,000 shares sold, net −11,404,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ewing Morris & Co. Investment Partners Ltd. | 3.15% | Add +5.0% | 10,500,000 | $7.2M |
"% of holder's portfolio" is EVOLENT HEALTH INC (EVH 3.5 12/01/29)'s weight in each manager's 13F, not the share of Evolent Health Inc. (evh 3.5 12/01/29) the manager owns.